Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-18-071671)

Filing Details

Accession Number:: 0001104659-18-071671
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-06 15:54:25
Reporting Period:: 2018-12-03

Accepted Time:: 2018-12-06 15:54:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1297184	Amphastar Pharmaceuticals Inc.	AMPH	Pharmaceutical Preparations (2834)	330702205

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611148	B. Jason Shandell	C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730	President And General Counsel	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-03	16,630	$10.48	200,445	No	4	M	Direct
Common Stock	Disposition	2018-12-03	16,630	$22.44	183,815	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2018-12-03	16,630	$0.00	16,630	$10.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-09-28	No	4	M	Direct

Footnotes

Includes 325 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2018.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2018.
Shares subject to the option are fully vested and immediately exercisable.